Cardiac Sarcoma — Primary Heart Sarcoma Explained
A cardiac sarcoma is a rare cancer that begins in the connective tissues of the heart itself — the muscle wall, the lining of a heart chamber, or a valve. Unlike the far commoner secondary tumours that spread to the heart from elsewhere, a primary cardiac tumour cancer of this kind grows from the heart's own tissue. Because its early symptoms — breathlessness, palpitations, swelling — look exactly like ordinary heart disease, a heart sarcoma is often diagnosed late. This page explains what cardiac sarcoma is, the symptoms to take seriously, the main subtypes, how it is found on echocardiography and cardiac MRI, and how CION's multidisciplinary sarcoma team plans treatment across 7 NABH-accredited Hyderabad locations.
- Rare but aggressive — primary cardiac sarcoma is uncommon and usually high-grade, so prompt specialist assessment matters
- Angiosarcoma is the most common subtype — usually arising in the right atrium near the heart's lining
- Diagnosed on imaging — echocardiography first, then cardiac MRI and CT to map the tumour
- Treated by a team — surgery, chemotherapy and radiation combined, planned at a sarcoma tumour board
on Panel
Survival Rate*
Treated
(800+ reviews)
What Is Cardiac Sarcoma?
A cardiac sarcoma is a malignant tumour that arises from the heart's own connective tissue — the muscle of the heart wall, the smooth lining inside a chamber (the endocardium), the outer covering (the pericardium), or a heart valve. It belongs to the wider family of soft tissue sarcomas — the overview hub covers in detail — cancers that grow from connective tissue rather than from the surface or glandular cells that give rise to most other cancers.
It is important to understand the difference between a primary and a secondary heart tumour. The great majority of cancers found in the heart are secondary — they have spread there from a cancer elsewhere in the body, such as the lung or breast. A primary cardiac tumour cancer is one that starts in the heart, and these are far rarer. Most primary heart tumours are in fact benign (a myxoma is the commonest), but when a primary heart tumour is malignant, a sarcoma is the usual diagnosis. So while any tumour of the heart is uncommon, a true primary heart sarcoma is rare even among them.
Because cardiac sarcomas are nearly always high-grade and fast-growing, and because the heart sits in a small, busy space where even a modest mass quickly disturbs blood flow, they tend to cause symptoms and to be discovered while still confined to the heart or having spread only locally. The challenge is that those early symptoms are easily mistaken for far commoner cardiac conditions, which is why a specialist eye on the imaging matters so much.
Symptoms of a Heart Sarcoma
There is no symptom that is unique to cardiac sarcoma. Instead, the tumour causes trouble in one of three ways, and the picture depends entirely on where in the heart it grows and what it obstructs. Recognising that a combination of these features is not adding up to a simple, common diagnosis is often the first clue.
Obstruction & Heart Failure
A mass projecting into a chamber or sitting across a valve can block the flow of blood, producing breathlessness, fatigue, swelling of the legs and abdomen, and the symptoms of heart failure — sometimes mistaken for a faulty valve or weak heart muscle.
Palpitations & Arrhythmia
A tumour involving the heart muscle can disturb the heart's electrical wiring, causing palpitations, an irregular heartbeat, dizziness, or fainting (syncope). Chest pain may occur when the tumour involves the pericardium.
Pericardial Effusion & Emboli
Fluid building up around the heart (a pericardial effusion), sometimes bloodstained, is a classic feature of right-sided angiosarcoma. Fragments of tumour can also break off and travel as emboli, causing stroke-like events or blocking blood vessels elsewhere.
Many patients also describe non-specific "constitutional" symptoms — unexplained fever, night sweats, weight loss, and feeling generally unwell — that do not fit any single heart condition. The crucial point is this: when breathlessness, swelling, or palpitations appear together with these systemic features, or when symptoms persist despite treatment for a presumed common heart problem, a structural cause such as a cardiac mass should be actively excluded with imaging.
Types of Primary Cardiac Sarcoma
Cardiac sarcomas are classified by the kind of connective tissue they most resemble under the microscope. The subtype, together with the grade, guides which combination of surgery, chemotherapy and radiation is likely to work — so getting the pathology right is the foundation of treatment.
Angiosarcoma
The most common primary cardiac sarcoma. It arises from the cells lining blood vessels and typically grows in the right atrium, close to the heart's surface and pericardium. Because of its location it commonly causes a bloodstained pericardial effusion and tamponade, and it has a strong tendency to spread to the lungs early.
Undifferentiated Pleomorphic Sarcoma
A high-grade sarcoma that does not resemble any specific tissue. In the heart it favours the left atrium, where it can obstruct flow across the mitral valve and mimic mitral valve disease — sometimes presenting almost identically to a benign left atrial myxoma.
Leiomyosarcoma & Synovial Sarcoma
Less common subtypes. Leiomyosarcoma arises from smooth muscle and also tends to involve the left atrium and the pulmonary veins. Synovial sarcoma, more often seen in the limbs, occasionally arises in the heart and pericardium and carries a specific genetic change that the pathologist can test for to confirm the diagnosis.
Why subtype matters: because a cardiac sarcoma frequently spreads to the lungs and elsewhere, its management overlaps heavily with the principles set out on our page on treatment options for metastatic sarcoma. The same chemotherapy agents that work for a particular soft tissue sarcoma subtype in the limb are generally the ones used when that subtype arises in the heart.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a Multidisciplinary Cardiac Sarcoma Plan
A primary heart sarcoma needs surgery, chemotherapy and radiation considered together, not one at a time. Our sarcoma tumour board reviews your echo, MRI and pathology and agrees a single coordinated plan — across 7 Hyderabad locations with same-week appointments.
How Cardiac Sarcoma Is Diagnosed and Staged
Diagnosis is a stepwise process. Each test answers a different question — is there a mass, what does it look like, where exactly is it, has it spread, and what is it made of — and the answers together decide whether and how surgery is possible.
Step 1 — Echocardiography Finds the Mass
An echocardiogram (ultrasound of the heart) is almost always the first test, often done to investigate breathlessness or a murmur. It shows whether a mass is present, which chamber it sits in, whether it is moving with the heartbeat, and whether it is obstructing a valve. A transoesophageal echo — where the probe is passed into the gullet behind the heart — gives a much clearer view of the atria and is frequently the test that first raises suspicion of something more sinister than a clot.
Step 2 — Cardiac MRI and CT Characterise It
A cardiac MRI is the key test for characterising a heart mass. Its tissue contrast can suggest whether a mass is likely benign or malignant, shows how deeply it invades the heart wall and whether it crosses into the pericardium, and maps its relationship to the great vessels — information the surgeon needs to judge whether a complete removal is achievable. A CT scan of the chest, abdomen and pelvis is added to look for spread to the lungs (the commonest site) and elsewhere, completing the staging picture.
Step 3 — Tissue Confirms the Diagnosis
A sarcoma can only be confirmed by examining tissue under the microscope. Sometimes this is obtained by an image-guided biopsy; often the diagnosis is made on the tissue removed at surgery, especially when the imaging already makes operation the right next step. The pathologist establishes the subtype and grade, and may run molecular tests — the principles are the same as for sarcomas elsewhere in the body, set out on our sarcoma treatment in Hyderabad page.
A note on PET-CT: a whole-body PET-CT is often used alongside CT to detect spread that other scans miss and to confirm that a cardiac mass is metabolically active, which supports a malignant rather than benign diagnosis. Staging is what separates a tumour confined to the heart — potentially curable with surgery — from one that has already spread and needs a systemic-first approach.
Treatment Options for Cardiac Sarcoma
No single treatment cures a cardiac sarcoma on its own. The best outcomes come from combining surgery, chemotherapy and radiation in a sequence chosen by a tumour board for the individual tumour, its subtype, and whether it has spread.
Surgical Resection
When the tumour is confined to the heart, complete surgical removal on cardiopulmonary bypass offers the only realistic chance of cure. The heart wall, chamber or valve is reconstructed after the tumour is taken out. The more complete the removal, the better the outlook — which is why an experienced surgical team and careful imaging matter.
Chemotherapy
Because cardiac sarcomas spread early, chemotherapy plays a central role — before surgery to shrink the tumour and treat microscopic spread, or after surgery and in advanced disease. Anthracycline-based regimens are the backbone, chosen by subtype, as detailed in our metastatic sarcoma guidance.
Radiation Therapy
Radiation may be used to improve local control after surgery, particularly when the margin is close or some tumour could not be removed. It is delivered carefully to limit dose to the surrounding heart and lung, and is one part of a combined plan rather than a stand-alone cure.
For selected tumours of the left atrium that cannot be reached adequately from inside the chest, specialist centres use cardiac autotransplantation — the heart is removed, the tumour is resected on the bench under direct vision, and the heart is reimplanted. Where the disease has already spread or surgery is not possible, the focus shifts to systemic treatment and controlling symptoms; the approaches mirror those described in treatment options for metastatic sarcoma.
Prognosis, Recovery and What to Expect
It is fair to be honest: cardiac sarcoma is an aggressive cancer, and its outlook is more guarded than that of many other sarcomas because of where it grows and its tendency to spread. But "aggressive" does not mean "untreatable." Several factors meaningfully change the outlook for an individual patient, and some of them are within reach of a good treatment plan.
The most important favourable factors are a tumour that is confined to the heart at diagnosis, the ability to achieve a complete surgical removal, a tumour on the left side of the heart (which is generally more resectable than a right-sided angiosarcoma), and a lower tumour grade. The presence of spread to the lungs at diagnosis is the single biggest adverse factor. This is why early, accurate imaging and a complete staging work-up are not just box-ticking — they directly shape whether surgery with curative intent is on the table.
Recovery after cardiac sarcoma surgery is recovery after major heart surgery, with a hospital stay, cardiac rehabilitation, and close monitoring of heart function. Treatment usually continues afterwards with chemotherapy, and surveillance with echocardiography and scans is lifelong because recurrence can occur. Throughout, the goals are honestly discussed — for some patients cure is realistic, for others the aim is the longest, best-quality life possible, and a good team is clear about which conversation it is having.
Indicative Cost in Hyderabad
| Procedure / Investigation | Approx. Cost (INR) | Notes |
|---|---|---|
| Echocardiogram (TTE / TEE) | ₹2,000 – ₹12,000 | First-line test to detect and locate a cardiac mass |
| Cardiac MRI (mass characterisation) | ₹10,000 – ₹25,000 | Key test to suggest benign vs malignant and map invasion |
| PET-CT (staging) | ₹18,000 – ₹35,000 | To detect spread to lungs and elsewhere |
| Cardiac Tumour Resection (on bypass) | ₹3,50,000 – ₹9,00,000+ | Varies widely by complexity and reconstruction required |
| Chemotherapy (per cycle, anthracycline-based) | ₹25,000 – ₹70,000 | Number of cycles depends on subtype and stage |
Costs are indicative. A personalised estimate is provided after your CION consultation. EMI options and cashless support through major TPAs, Aarogyasri, CGHS, ECHS & ESI are available for eligible patients.
Why Patients Choose CION for Rare Sarcoma Care
A primary heart sarcoma is exactly the kind of rare, high-stakes diagnosis that needs a coordinated specialist team rather than a single doctor working alone. Here is why patients trust CION.
AIIMS-trained surgical oncologist
Multidisciplinary tumour board
Specialist sarcoma pathology
Advanced cardiac & whole-body imaging
Coordinated cardiac surgical partners
Free written second opinion
7 NABH-accredited Hyderabad locations
EMI facility & insurance accepted
4.8 / 5 Google rating
Have a Cardiac Mass Reviewed by Sarcoma Specialists
If a scan has shown a tumour in your heart, the most useful first step is a specialist review of the imaging. Talk to our sarcoma team about whether it points to a primary heart sarcoma and what your options are.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Cardiac Sarcoma — Frequently Asked Questions
What is cardiac sarcoma?
Cardiac sarcoma is a rare malignant cancer that arises from the heart's own connective tissue — the muscle of the heart wall, the lining of a chamber, the pericardium, or a valve. It is a "primary" heart tumour, meaning it starts in the heart rather than spreading there from elsewhere. Most primary heart tumours are actually benign (a myxoma is the commonest), but when a primary heart tumour is malignant it is usually a sarcoma. Cardiac sarcomas are nearly always high-grade and aggressive, and the most common subtype is angiosarcoma, which typically grows in the right atrium.
What are the symptoms of a primary heart sarcoma?
There is no symptom unique to cardiac sarcoma — it causes trouble by obstructing blood flow, disturbing the heart's rhythm, or producing fluid around the heart. Patients may have breathlessness, fatigue, swelling of the legs or abdomen, palpitations or an irregular heartbeat, chest pain, fainting, or a bloodstained pericardial effusion. Many also have non-specific features such as unexplained fever, weight loss and feeling generally unwell. Because these mimic common heart conditions, a cardiac mass should be actively excluded with imaging when symptoms persist or do not add up to a simple diagnosis.
How is cardiac sarcoma diagnosed?
Diagnosis is stepwise. An echocardiogram (often a transoesophageal echo) usually finds the mass and shows which chamber it is in. A cardiac MRI is the key test to characterise it — suggesting whether it is benign or malignant and showing how deeply it invades — while a CT of the chest, abdomen and pelvis, often with PET-CT, looks for spread, most commonly to the lungs. A sarcoma can only be confirmed on tissue examined under the microscope, obtained either by an image-guided biopsy or at the time of surgery, which establishes the subtype and grade.
Can cardiac sarcoma be cured or treated?
It can be treated, and in selected patients treated with curative intent. The best chance of cure is a complete surgical removal of a tumour that is still confined to the heart, performed on cardiopulmonary bypass with reconstruction of the affected structures. Surgery is almost always combined with chemotherapy — before or after the operation — because these sarcomas tend to spread early, and radiation may be added for local control. For some left atrial tumours, specialist centres use cardiac autotransplantation. When the cancer has already spread, the focus moves to systemic treatment and quality of life.
How is a cardiac sarcoma told apart from a benign myxoma?
This distinction is central, because a benign myxoma is far more common and is cured by simple removal, whereas a sarcoma needs combined treatment. The difference is suggested by the pattern on imaging — a myxoma is typically a smooth, stalked mass in the left atrium, while a sarcoma is more often broad-based, invades the heart wall, may cross into the pericardium, and is metabolically active on PET-CT. Ultimately the diagnosis is confirmed on tissue under the microscope, which is why having a cardiac mass reviewed by a team that includes a sarcoma specialist is so important.